tech
SandboxAQ brings its drug discovery models to Claude — no PhD in computing required
Other venture-backed companies like Chai Discovery and Isomorphic Labs have raced to build better models. SandboxAQ is betting that access is the bigger obstacle and that Claude solves it.
TL;DR
- SandboxAQ is making its drug discovery and materials science AI models more accessible.
- The company is integrating its 'physics-grounded' large quantitative models (LQMs) into Anthropic's Claude.
- This approach bypasses the need for specialized computing infrastructure, allowing use through a conversational interface.
- LQMs can perform quantum chemistry calculations and simulate molecular dynamics and microkinetics.
- SandboxAQ, chaired by former Google CEO Eric Schmidt, has raised over $950 million and focuses on making AI tools usable rather than solely on improving the models themselves.